Published in Vaccine Weekly, August 2nd, 2006
The award for $2.3 million continues the DOD's support for the preclinical development of LigoCyte's intranasal, dual-antigen vaccine.
Protection data from LigoCyte's vaccine was recently reported in the May, 2006 journal Vaccine. The new vaccine provided 100% protection from an inhaled anthrax challenge in an animal study at Battelle Memorial Institute. "Our vaccine not only prevented death in all of the immunized animals, but it also...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly